Even after Merck & Co.’s Keytruda has climbed to the top of the industry’s sales charts and racked up dozens of FDA-a | A ...

Merck (NYSE:MRK) announced on Thursday that its Phase 3 KEYNOTE-B96 trial for its anti-PD-1 therapy Keytruda reached the ...

Merck's KEYNOTE-B96 trial shows Keytruda with chemotherapy improves survival in platinum-resistant recurrent ovarian cancer ...

Corcept Therapeutics CORT announced that it has submitted a marketing authorization application (MAA) seeking approval for ...

Carla Peoples thought her symptoms were due to another problem, but was shocked to be diagnosed with ovarian cancer. She ...

Ovarian cancer is an abnormal growth of cells or tumors in the ovaries. Some forms of ovarian cancer are more aggressive than ...

Beyond medical interventions, diet and lifestyle significantly enhance ovarian cancer recovery and quality of life. A balanced diet, rich in whole foo ...

Samer A. Srour, MB ChB, MS, has long hoped the remarkable success of chimeric antigen receptor therapy for treatment of hematologic malignancies could be replicated in other cancer types.“There is a ...

German biotech firm Tubulis said on Wednesday it had raised 308 million euros ($358 million) in its biggest financing round ...

FARGO, N.D. (Valley News Live) - A 20-year-old college student from the Fargo-Moorhead area is turning her unexpected cancer ...

One study from Canada concluded in 2023 that hairdressing and accountancy, among other jobs, correlated with a higher risk of ovarian cancer.